glp 1 and sglt2 Common systemic effects of either inhibitors or GLP-1R agonists MCT2D | The Benefits of
Description
These features make GLP-1 RAs an advantageous alternative to rapid-acting insulin for patients inadequately controlled on a long-acting basal insulin

If persistent tachycardia occurs, healthcare professionals may consider further investigations such as ECG, thyroid function tests, electrolytes and medication review

Has systemic estradiol and progesterone status been evaluated by a menopause-informed clinician

*Not everyone naturally has the Akkermansia muciniphila strain in their gut microbiome, our GLP-1 supports growth in those who naturally have the strain

In a similar study, patients with an A1C 7.5% reduced their insulin glargine dose by 30% when beginning tirzepatide
